Tilray

Aphria, Tilray Subsidiary, Secures New Medical Cannabis Production License in Germany

Aphria RX, a subsidiary of Tilray, has secured a new license for medical cannabis cultivation in Germany to significantly expand…

4 months ago

Tilray Sirius Is Making its Mark Internationally

Tilray Sirius is making its mark internationally, most recently becoming available in Polish pharmacies. The strain features a unique terpene…

1 year ago

Tilray Posts $52.5 Million Profit Despite Retail Cannabis Decline

Tilray Brands recently saw its share of the Canadian retail cannabis market decline, but the producer said it was encouraged…

3 years ago

Mergers and job losses: the cannabis industry after Aphria and Tilray

When giants clash, who pays the price? With Tilray and Aphria merging the world of hemp will be shaken up,…

4 years ago

Two large cannabis companies merge and a giant is born

Two large cannabis companies, Aphria and Tilray, are in advanced talks to merge. An announcement was made this week and…

4 years ago

European cannabis market a prime choice for investors

With legal barriers out of the way, countless investors placed their bets on Canadian and American cannabis companies. The situation…

5 years ago

Marijuana markets – time to invest in marijuana companies

Medical marijuana is already permitted in most states of the U.S., and 10 states have legalized cannabis for recreational use.…

5 years ago

Why there is light at the end of the tunnel for cannabis investors

The market has seen a significant downturn and big cannabis names haven’t escaped unscathed. One might think that betting on…

5 years ago

Marijuana legalization and how to profit from marijuana stocks

If you're not sure where to begin when it comes to capitalizing on cannabis, you're not alone. But it's not…

5 years ago

Legal investment in marijuana around the world

Medical marijuana is already legal in 30 countries. If added to the countries in which it is available for recreational…

5 years ago